OP
RYTM icon

ORG Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

ORG Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.96K Buy
37
+5
+16% +$530 ﹤0.01% 1282
2025
Q3 		$3.23K Buy
32
+8
+33% +$743 ﹤0.01% 1223
2025
Q2 		$1.57K Hold
24
– – ﹤0.01% 1275
2025
Q1 		$1.2K Buy
+24
New +$1.33K ﹤0.01% 1146
2024
Q3 		– Sell
-1,206
Closed -$51.5K – 1338
2024
Q2 		$51.5K Buy
+1,206
New +$48.1K 0.01% 778

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORG Partners's RYTM Position: Q4 2025 in Review

ORG Partners increased its Rhythm Pharmaceuticals (RYTM) stake by 16% in Q4 2025, buying an estimated $530 and bringing the position to 37 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

ORG Partners first reported a position in RYTM in Q2 2024 and has held it in 5 quarters since. The position peaked at $51.5K in Q2 2024. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • ORG Partners held 37 shares of Rhythm Pharmaceuticals worth $3.96K as of Q4 2025.
  • ORG Partners bought 5 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $530.
  • Rhythm Pharmaceuticals made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1282 holding.
  • ORG Partners first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • ORG Partners's Rhythm Pharmaceuticals position peaked at $51.5K in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.